Can Fite Biopharma
CANF
#9757
Rank
HK$0.10 B
Marketcap
HK$15.67
Share price
0.18%
Change (1 day)
0.06%
Change (1 year)

Revenue for Can Fite Biopharma (CANF)

Revenue in 2023 (TTM): HK$5.82 Million

According to Can Fite Biopharma 's latest financial reports the company's current revenue (TTM ) is HK$5.78 Million. a decrease over the revenue in the year 2022 that were of HK$6.32 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Can Fite Biopharma from 2011 to 2023

Annual revenue

Year Revenue Change
2023 HK$5.8 M-8.31%
2022 HK$6.32 M-4.85%
2021 HK$6.65 M12.45%
2020 HK$5.91 M-62.62%
2019 HK$15.82 M-47.1%
2018 HK$29.91 M356.17%
2017 HK$6.55 M398.91%
2016 HK$1.31 M2.96%
2015 HK$1.27 M
2014 N/A
2013 N/A
2012 N/A-100%
2011 HK$3.79 M